Illicit Supply of Fentanyl and Other Synthetic Opioids
Transitioning Markets and Evolving Challenges
Expert InsightsPublished Jul 25, 2019
Testimony presented before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations, on July 25, 2019.
Related Content
Topics
Document Details
- Copyright: RAND Corporation
- Availability: Web-Only
- Year: 2019
- Pages: 16
- DOI: https://doi.org/10.7249/CT515
- Document Number: CT-515
Citation
RAND Style Manual
Chicago Manual of Style
Pardo, Bryce, Illicit Supply of Fentanyl and Other Synthetic Opioids: Transitioning Markets and Evolving Challenges, RAND Corporation, CT-515, 2019. As of September 18, 2024: https://www.rand.org/pubs/testimonies/CT515.html
Pardo, Bryce, Illicit Supply of Fentanyl and Other Synthetic Opioids: Transitioning Markets and Evolving Challenges. Santa Monica, CA: RAND Corporation, 2019. https://www.rand.org/pubs/testimonies/CT515.html.
Research conducted by
This publication is part of the RAND testimony series. RAND testimonies record testimony presented by RAND associates to federal, state, or local legislative committees; government-appointed commissions and panels; and private review and oversight bodies.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.